Signals that cause immune cells to fight infections
Inflazome has raised €56M across 3 funding rounds from 4 investors, most recently a round in Jan 2019. Based in Dublin, Ireland; founded 2016; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2019-01-01 | Other | €873k | Michael J. Fox Foundation | View deal → |
| 2018-11-19 | Series B | €40M | Forbion Capital Partners | View deal → |
| 2016-09-01 | Series A | €15M | Fountain Healthcare Partners,Novartis Venture Fund | View deal → |
